New study shows reactions in the brain in people who were given psilocybin
Researchers at Washington University studied psilocybin's impact on the brain using functional M.R.I. scans. Results in Nature showed significant changes in introspective brain areas. Psilocybin's effects lingered post-drug, hinting at mental health benefits beyond placebos.
Read original articleA recent study conducted by researchers at Washington University School of Medicine in St. Louis explored the effects of psilocybin, the compound found in "magic mushrooms," on the human brain. The study involved brain scans of participants who were given psilocybin in a controlled setting and then underwent functional M.R.I. scans. The results, published in the journal Nature, revealed significant changes in brain activity patterns, particularly in areas related to introspective thinking and self-definition. The study found that the disruption caused by psilocybin was three times greater than that caused by a placebo. Interestingly, scans taken days and weeks later showed a small but significant lingering effect on the brain, suggesting that the drug's impact persisted even after it had left the body. Researchers believe that these findings could provide insights into how psychedelic compounds like psilocybin may offer relief from mental health disorders such as depression and anxiety. The study also highlighted the importance of the psychedelic experience in therapeutic processes and challenged the notion that improvements from psychedelic therapies are solely due to the placebo effect.
Related
Next-generation psychedelics: should new agents skip the trip?
Companies are investing in next-generation psychedelics to enhance mental health treatment, focusing on reducing psychoactive effects while maintaining therapeutic benefits. Despite expanding interest and investments, questions persist about efficacy and cost-effectiveness.
Effects of psychedelics on neurogenesis and brain plasticity A systematic review
A systematic review examines psychedelics' impact on neurogenesis and brain plasticity, suggesting their potential in treating mood disorders. The study analyzed 205 articles, categorizing findings on various compounds' effects. It includes both experimental and human studies, aiming to inform new therapeutic approaches for neuropsychiatric conditions.
Mexico may legalize magic mushrooms
Mexico is considering legalizing magic mushrooms for therapeutic use under medical supervision. The move sparks debate over preserving Indigenous practices while ensuring regulation and cultural respect. Supporters aim to blend science with traditional medicine.
Why don't we know how antidepressants work yet?
Researchers at Imperial College London study antidepressants using 'mini-brain' organoids. SSRIs' effectiveness, mechanisms, and controversies are debated, with focus on biochemical vs. social perspectives. Optimism exists for future antidepressant advancements.
Psilocybin Desynchronizes the Human Brain
A 2024 Nature study shows psilocybin disrupts human brain connectivity, affecting the default mode network significantly. This research suggests therapeutic potential by altering brain connections, notably between the hippocampus and default mode network.
Related
Next-generation psychedelics: should new agents skip the trip?
Companies are investing in next-generation psychedelics to enhance mental health treatment, focusing on reducing psychoactive effects while maintaining therapeutic benefits. Despite expanding interest and investments, questions persist about efficacy and cost-effectiveness.
Effects of psychedelics on neurogenesis and brain plasticity A systematic review
A systematic review examines psychedelics' impact on neurogenesis and brain plasticity, suggesting their potential in treating mood disorders. The study analyzed 205 articles, categorizing findings on various compounds' effects. It includes both experimental and human studies, aiming to inform new therapeutic approaches for neuropsychiatric conditions.
Mexico may legalize magic mushrooms
Mexico is considering legalizing magic mushrooms for therapeutic use under medical supervision. The move sparks debate over preserving Indigenous practices while ensuring regulation and cultural respect. Supporters aim to blend science with traditional medicine.
Why don't we know how antidepressants work yet?
Researchers at Imperial College London study antidepressants using 'mini-brain' organoids. SSRIs' effectiveness, mechanisms, and controversies are debated, with focus on biochemical vs. social perspectives. Optimism exists for future antidepressant advancements.
Psilocybin Desynchronizes the Human Brain
A 2024 Nature study shows psilocybin disrupts human brain connectivity, affecting the default mode network significantly. This research suggests therapeutic potential by altering brain connections, notably between the hippocampus and default mode network.